A non-linear mixed effect modelling approach for metabolite correction of the arterial input function in PET studies
暂无分享,去创建一个
Alessandra Bertoldo | Mattia Veronese | Roger N. Gunn | Stefano Zamuner | R. Gunn | M. Veronese | A. Bertoldo | S. Zamuner
[1] Roger N. Gunn,et al. Tracer Kinetic Modelling of the 5-HT1A Receptor Ligand [carbonyl-11C]WAY-100635 , 1998, NeuroImage.
[2] S. Gunn,et al. Positron Emission Tomography Compartmental Models , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] N. Simpson,et al. PET Studies of Binding Competition between Endogenous Dopamine and the D1 Radiotracer [11C]NNC 756 , 1998, NeuroImage.
[4] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[5] W. Moll,et al. Problems and pitfalls in estimating average pharmacokinetic parameters , 2004, European Journal of Clinical Pharmacology.
[6] Fang Yuan,et al. A general method of Bayesian estimation for parametric imaging of the brain , 2008, NeuroImage.
[7] Sylvain Houle,et al. Positron Emission Tomography Quantification of [11C]-(+)-PHNO Binding in the Human Brain , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] R. V. Van Heertum,et al. Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] Sylvain Houle,et al. In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. , 2002, Nuclear medicine and biology.
[10] John D. Beaver,et al. Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist , 2010, Biological Psychiatry.
[11] A. Mallet. A maximum likelihood estimation method for random coefficient regression models , 1986 .
[12] W C Eckelman,et al. Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] E. Vonesh,et al. Mixed-effects nonlinear regression for unbalanced repeated measures. , 1992, Biometrics.
[14] D. Bates,et al. Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.
[15] Alan A. Wilson,et al. Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist , 2010, Biological Psychiatry.
[16] H. Vincent Poor,et al. An Introduction to Signal Detection and Estimation , 1994, Springer Texts in Electrical Engineering.
[17] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] Deborah Dewar,et al. Radiosynthesis and evaluation of novel histamine H3 tracers , 2009 .
[19] L. Sheiner,et al. Modelling of individual pharmacokinetics for computer-aided drug dosage. , 1972, Computers and biomedical research, an international journal.
[20] J. Logan. Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.
[21] Alan A. Wilson,et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.
[22] Lewis B. Sheiner,et al. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data , 1980, Journal of Pharmacokinetics and Biopharmaceutics.
[23] Mark Jenkinson,et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.
[24] Marie Davidian,et al. Nonlinear Models for Repeated Measurement Data , 1995 .
[25] Vincent J Cunningham,et al. Validation of a Tracer Kinetic Model for the Quantification of 5-HT2A Receptors in Human Brain with [11C]MDL 100,907 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] Gender dependent rate of metabolism of the opioid receptor-PET ligand [18F]fluoroethyldiprenorphine. , 2006, Nuklearmedizin. Nuclear medicine.
[27] Alessandra Bertoldo,et al. Nonlinear Mixed Effects to Improve Glucose Minimal Model Parameter Estimation: A Simulation Study in Intensive and Sparse Sampling , 2009, IEEE Transactions on Biomedical Engineering.
[28] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] Sylvain Houle,et al. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. , 2005, Journal of medicinal chemistry.